MICHAEL INGRAM
- Type
- Physician · Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Psychiatry
- Where
- BAY CITY, MI
- NPI
- 1295767283
- Received
- $255,284 in 491 records, 2019 to 2025
- Source
- CMS Open Payments search ↗
By year
| Program year | Kind | Records | Amount |
|---|---|---|---|
| 2025 | General payment | 68 | $36,482 |
| 2024 | General payment | 59 | $44,577 |
| 2023 | General payment | 52 | $17,684 |
| 2022 | General payment | 82 | $44,473 |
| 2021 | General payment | 44 | $28,845 |
| 2020 | General payment | 48 | $26,805 |
| 2019 | General payment | 138 | $56,415 |
By company
| Company | Records | Amount | Years |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | 133 | $91,892 | 2019–2025 |
| Alkermes, Inc. | 103 | $73,024 | 2019–2024 |
| Otsuka America Pharmaceutical, Inc. | 80 | $33,941 | 2019–2025 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 36 | $25,641 | 2020–2025 |
| Teva Pharmaceuticals USA, Inc. | 37 | $21,331 | 2019–2023 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 12 | $7,538 | 2019–2025 |
| Neurocrine BioSciences, Inc. | 23 | $359 | 2019–2025 |
| Validus Pharmaceuticals LLC | 3 | $346 | 2019–2021 |
| Lundbeck LLC | 15 | $255 | 2019–2025 |
| ABBVIE INC. | 10 | $206 | 2022–2024 |
| Sunovion Pharmaceuticals Inc. | 10 | $150 | 2019–2021 |
| Axsome Therapeutics, Inc. | 7 | $130 | 2023–2025 |
| Indivior Inc. | 4 | $96 | 2019–2025 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $91 | 2019–2025 |
| Sage Therapeutics, LLC | 2 | $88 | 2022–2025 |
| ACADIA Pharmaceuticals Inc | 1 | $53 | 2022 |
| USWM, LLC | 2 | $27 | 2023 |
| Antares Pharma, Inc. | 1 | $17 | 2024 |
| Corium, LLC | 1 | $17 | 2024 |
| Avanir Pharmaceuticals, Inc. | 1 | $17 | 2019 |
| Tris Pharma Inc | 1 | $15 | 2020 |
| E.R. Squibb & Sons, L.L.C. | 1 | $14 | 2025 |
| IDORSIA PHARMACEUTICALS US INC | 1 | $12 | 2023 |
| Vanda Pharmaceuticals Inc. | 1 | $12 | 2020 |
By nature of payment
| Nature | Records | Amount |
|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a v | 98 | $191,826 |
| Travel and Lodging | 74 | $29,284 |
| Consulting Fee | 8 | $21,640 |
| Food and Beverage | 307 | $12,495 |
| Education | 4 | $37 |
Records
| Date | Company | Amount | Nature | Form | Product | Study | Year |
|---|---|---|---|---|---|---|---|
| 2025-12-18 | Janssen Pharmaceuticals, Inc | $675 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-12-16 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $158 | Travel and Lodging | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,775 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-12 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,220 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-10 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $4,440 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $125 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-12-04 | Takeda Pharmaceuticals U.S.A., Inc. | $18 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-12-02 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $69 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $24 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-19 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $72 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-11-17 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $3,885 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-15 | Neurocrine BioSciences, Inc. | $11 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $776 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $306 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $144 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $117 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $65 | Travel and Lodging | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $56 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $49 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $34 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-10-11 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $33 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-09-27 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-09-10 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-08-26 | Neurocrine BioSciences, Inc. | $20 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-07-23 | E.R. Squibb & Sons, L.L.C. | $14 | Food and Beverage | Cash or cash equivalent | COBENFY Drug, Neuroscience | 2025 | |
| 2025-07-15 | Lundbeck LLC | $30 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-07-14 | Janssen Pharmaceuticals, Inc | $450 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-07-08 | Takeda Pharmaceuticals U.S.A., Inc. | $13 | Food and Beverage | In-kind items and services | TRINTELLIX Drug, NEUROSCIENCE | 2025 | |
| 2025-07-07 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $27 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-07-01 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-06-16 | Janssen Pharmaceuticals, Inc | $2,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-06-13 | Janssen Pharmaceuticals, Inc | $74 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-06-11 | Neurocrine BioSciences, Inc. | $10 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-06-04 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $2,497 | Consulting Fee | Cash or cash equivalent | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-18 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $16 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-05-15 | Axsome Therapeutics, Inc. | $18 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2025 | |
| 2025-05-13 | Sage Therapeutics, LLC | $25 | Food and Beverage | In-kind items and services | 2025 | ||
| 2025-05-06 | Neurocrine BioSciences, Inc. | $7 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-05-01 | Indivior Inc. | $17 | Food and Beverage | In-kind items and services | SUBLOCADE Drug, OUD | 2025 | |
| 2025-04-29 | Otsuka America Pharmaceutical, Inc. | $96 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-04-16 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-08 | Neurocrine BioSciences, Inc. | $7 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-04-01 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $73 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2025 | |
| 2025-03-26 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-21 | Janssen Pharmaceuticals, Inc | $165 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-21 | Janssen Pharmaceuticals, Inc | $46 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-21 | Janssen Pharmaceuticals, Inc | $5 | Food and Beverage | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-18 | Lundbeck LLC | $19 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2025 | |
| 2025-03-12 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-03-05 | Janssen Pharmaceuticals, Inc | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-05 | Janssen Pharmaceuticals, Inc | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-04 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-03-04 | Janssen Pharmaceuticals, Inc | $1,575 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-28 | Janssen Pharmaceuticals, Inc | $1,127 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-27 | Janssen Pharmaceuticals, Inc | $229 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-27 | Janssen Pharmaceuticals, Inc | $211 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-27 | Janssen Pharmaceuticals, Inc | $117 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-27 | Janssen Pharmaceuticals, Inc | $37 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-25 | Janssen Pharmaceuticals, Inc | $5 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-24 | Janssen Pharmaceuticals, Inc | $816 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-02-21 | Janssen Pharmaceuticals, Inc | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2025 | |
| 2025-01-21 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $18 | Food and Beverage | In-kind items and services | REJOYN Device, PSYCHIATRY | 2025 | |
| 2025-01-16 | Neurocrine BioSciences, Inc. | $73 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-15 | Neurocrine BioSciences, Inc. | $10 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-08 | Neurocrine BioSciences, Inc. | $6 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2025 | |
| 2025-01-03 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $1,113 | Consulting Fee | Cash or cash equivalent | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2025 | |
| 2024-12-05 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-12-04 | Alkermes, Inc. | $27 | Food and Beverage | In-kind items and services | VIVITROL Drug, CNS | 2024 | |
| 2024-11-26 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2024 | |
| 2024-11-20 | Janssen Pharmaceuticals, Inc | $128 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-11-20 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-11-19 | Janssen Pharmaceuticals, Inc | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-11-04 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-31 | Janssen Pharmaceuticals, Inc | $1,143 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-30 | Janssen Pharmaceuticals, Inc | $117 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-30 | Neurocrine BioSciences, Inc. | $18 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-10-29 | Janssen Pharmaceuticals, Inc | $11,760 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-23 | Janssen Pharmaceuticals, Inc | $116 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2024 | |
| 2024-10-19 | Janssen Pharmaceuticals, Inc | $59 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-19 | Janssen Pharmaceuticals, Inc | $58 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-19 | Janssen Pharmaceuticals, Inc | $40 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-18 | Janssen Pharmaceuticals, Inc | $1,085 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-18 | Janssen Pharmaceuticals, Inc | $444 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-18 | Janssen Pharmaceuticals, Inc | $147 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-10-11 | Otsuka America Pharmaceutical, Inc. | $14 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-10-08 | Janssen Pharmaceuticals, Inc | $5 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-09-18 | Axsome Therapeutics, Inc. | $15 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-09-16 | Janssen Pharmaceuticals, Inc | $147 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-09-16 | Janssen Pharmaceuticals, Inc | $35 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-09-09 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $4,374 | Consulting Fee | Cash or cash equivalent | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-08-27 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-23 | Janssen Pharmaceuticals, Inc | $311 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-22 | Janssen Pharmaceuticals, Inc | $159 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-08-14 | Neurocrine BioSciences, Inc. | $15 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-08-08 | Janssen Pharmaceuticals, Inc | $5 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-07-26 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $46 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-26 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $46 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-26 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $23 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-26 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $23 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-25 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $744 | Travel and Lodging | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-25 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $208 | Travel and Lodging | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-25 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $109 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2024 | |
| 2024-07-23 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-07-02 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-06-27 | Janssen Pharmaceuticals, Inc | $111 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-06-25 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19 | Food and Beverage | In-kind items and services | CAPLYTA Drug, PSYCHIATRY | 2024 | |
| 2024-06-21 | Janssen Pharmaceuticals, Inc | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-06-20 | Otsuka Pharmaceutical Development & Commercialization, Inc. | $810 | Consulting Fee | Cash or cash equivalent | ABILIFY ASIMTUFII Drug, PSYCHIATRY | 2024 | |
| 2024-06-12 | Janssen Pharmaceuticals, Inc | $900 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-06-06 | Axsome Therapeutics, Inc. | $24 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-06-06 | ABBVIE INC. | $24 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-05-02 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-05-02 | Neurocrine BioSciences, Inc. | $14 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2024-04-25 | Janssen Pharmaceuticals, Inc | $115 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-18 | Alkermes, Inc. | $96 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2024 | |
| 2024-04-16 | ABBVIE INC. | $20 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-04-05 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-04 | Corium, LLC | $17 | Food and Beverage | In-kind items and services | Azstarys Drug, CNS Stimulant for ADHD | 2024 | |
| 2024-04-01 | Janssen Pharmaceuticals, Inc | $3,150 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-04-01 | Janssen Pharmaceuticals, Inc | $11 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-03-19 | Janssen Pharmaceuticals, Inc | $124 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2024 | |
| 2024-03-11 | Antares Pharma, Inc. | $17 | Food and Beverage | In-kind items and services | XYOSTED Drug, TESTOSTERONE REPLACEMENT THERAPY | 2024 | |
| 2024-03-07 | ABBVIE INC. | $18 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2024 | |
| 2024-01-23 | Axsome Therapeutics, Inc. | $17 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2024 | |
| 2024-01-10 | Neurocrine BioSciences, Inc. | $19 | Food and Beverage | In-kind items and services | INGREZZA Drug, Neuropsychiatry | 2024 | |
| 2023-12-28 | ABBVIE INC. | $26 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-12-28 | Indivior Inc. | $23 | Food and Beverage | In-kind items and services | PERSERIS Drug, BH | 2023 | |
| 2023-11-28 | ABBVIE INC. | $22 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-10-18 | Otsuka America Pharmaceutical, Inc. | $24 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-10-13 | Otsuka America Pharmaceutical, Inc. | $15 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-10-13 | Otsuka America Pharmaceutical, Inc. | $2 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-10-11 | Otsuka America Pharmaceutical, Inc. | $99 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-09-21 | Teva Pharmaceuticals USA, Inc. | $840 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | UZEDY Drug, Neurology | 2023 | |
| 2023-09-20 | Janssen Pharmaceuticals, Inc | $81 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-09-12 | Axsome Therapeutics, Inc. | $19 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-08-31 | Axsome Therapeutics, Inc. | $21 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-08-30 | Teva Pharmaceuticals USA, Inc. | $13 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-08-30 | Teva Pharmaceuticals USA, Inc. | $1 | Food and Beverage | In-kind items and services | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-08-29 | Otsuka America Pharmaceutical, Inc. | $22 | Food and Beverage | In-kind items and services | ABILIFY MAINTENA Drug, PSYCHIATRY | 2023 | |
| 2023-08-16 | Janssen Pharmaceuticals, Inc | $34 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-08-15 | Axsome Therapeutics, Inc. | $13 | Food and Beverage | In-kind items and services | Auvelity Drug, Psychology/Psychiatric | 2023 | |
| 2023-07-25 | Otsuka America Pharmaceutical, Inc. | $19 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-07-20 | Teva Pharmaceuticals USA, Inc. | $990 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | Austedo XR Drug, Central Nervous System | 2023 | |
| 2023-06-23 | ABBVIE INC. | $13 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-06-13 | IDORSIA PHARMACEUTICALS US INC | $12 | Food and Beverage | In-kind items and services | QUVIVIQ Drug, INSOMNIA | 2023 | |
| 2023-06-09 | Alkermes, Inc. | $7,700 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ARISTADA Drug, CNS | 2023 | |
| 2023-05-23 | Otsuka America Pharmaceutical, Inc. | $9 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-05-22 | Teva Pharmaceuticals USA, Inc. | $50 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-21 | Otsuka America Pharmaceutical, Inc. | $95 | Food and Beverage | In-kind items and services | 2023 | ||
| 2023-05-20 | Alkermes, Inc. | $35 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-16 | Janssen Pharmaceuticals, Inc | $55 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-16 | Janssen Pharmaceuticals, Inc | $18 | Food and Beverage | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-16 | Janssen Pharmaceuticals, Inc | $17 | Food and Beverage | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-13 | Alkermes, Inc. | $545 | Travel and Lodging | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-13 | Alkermes, Inc. | $401 | Travel and Lodging | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-13 | Alkermes, Inc. | $200 | Food and Beverage (4 payments) | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-12 | Alkermes, Inc. | $194 | Food and Beverage (4 payments) | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-12 | Alkermes, Inc. | $125 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-12 | Alkermes, Inc. | $118 | Travel and Lodging | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-11 | Janssen Pharmaceuticals, Inc | $3,750 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-11 | Alkermes, Inc. | $125 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2023 | |
| 2023-05-06 | Janssen Pharmaceuticals, Inc | $79 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-06 | Janssen Pharmaceuticals, Inc | $59 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-06 | Janssen Pharmaceuticals, Inc | $39 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-05 | Janssen Pharmaceuticals, Inc | $682 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-05 | Janssen Pharmaceuticals, Inc | $649 | Travel and Lodging | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-05 | Janssen Pharmaceuticals, Inc | $149 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-05 | Janssen Pharmaceuticals, Inc | $35 | Food and Beverage | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-05-03 | Janssen Pharmaceuticals, Inc | $84 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2023-04-07 | Teva Pharmaceuticals USA, Inc. | $25 | Food and Beverage | In-kind items and services | AUSTEDO Drug, Central Nervous System | 2023 | |
| 2023-04-01 | USWM, LLC | $13 | Food and Beverage | In-kind items and services | Lucemyra Drug, Psychiatry/Psychology | 2023 | |
| 2023-04-01 | USWM, LLC | $13 | Food and Beverage | In-kind items and services | Lucemyra Drug, Psychiatry/Psychology | 2023 | |
| 2023-03-14 | Otsuka America Pharmaceutical, Inc. | $20 | Food and Beverage | In-kind items and services | REXULTI Drug, PSYCHIATRY | 2023 | |
| 2023-03-07 | ABBVIE INC. | $17 | Food and Beverage | In-kind items and services | VRAYLAR Drug, NEUROSCIENCE | 2023 | |
| 2023-02-09 | Alkermes, Inc. | $14 | Education | In-kind items and services | Vivitrol Drug, CNS | 2023 | |
| 2023-02-01 | Janssen Pharmaceuticals, Inc | $33 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2023 | |
| 2023-01-10 | Janssen Pharmaceuticals, Inc | $24 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2023 | |
| 2022-12-08 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-12-04 | Alkermes, Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | LYBALVI Drug, CNS | 2022 | |
| 2022-11-22 | Lundbeck LLC | $15 | Food and Beverage | Cash or cash equivalent | BRINTELLIX Drug, PSYCHIATRY | 2022 | |
| 2022-11-17 | Janssen Pharmaceuticals, Inc | $2,730 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-11-17 | Janssen Pharmaceuticals, Inc | $115 | Travel and Lodging | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-11-17 | Janssen Pharmaceuticals, Inc | $71 | Food and Beverage | In-kind items and services | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-11-16 | Alkermes, Inc. | $1,690 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ARISTADA Drug, CNS | 2022 | |
| 2022-11-15 | Alkermes, Inc. | $71 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2022 | |
| 2022-11-11 | Sage Therapeutics, LLC | $63 | Food and Beverage | In-kind items and services | 2022 | ||
| 2022-11-03 | Janssen Pharmaceuticals, Inc | $78 | Food and Beverage | In-kind items and services | SPRAVATO Drug, Neuroscience | 2022 | |
| 2022-11-02 | Alkermes, Inc. | $19 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-11-01 | Janssen Pharmaceuticals, Inc | $780 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-10-26 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-10-24 | Alkermes, Inc. | $2,200 | Compensation for services other than consulting, including serving as faculty or as a speaker at a v | Cash or cash equivalent | ARISTADA Drug, CNS | 2022 | |
| 2022-10-20 | Alkermes, Inc. | $23 | Food and Beverage | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-10-13 | Janssen Pharmaceuticals, Inc | $3,120 | Consulting Fee | Cash or cash equivalent | INVEGA SUSTENNA Drug, Neuroscience | 2022 | |
| 2022-10-12 | Alkermes, Inc. | $3,100 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2022 | |
| 2022-10-12 | Alkermes, Inc. | $118 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2022 | |
| 2022-10-12 | Alkermes, Inc. | $104 | Travel and Lodging | In-kind items and services | ARISTADA Drug, CNS | 2022 | |
| 2022-10-12 | Alkermes, Inc. | $104 | Travel and Lodging | In-kind items and services | LYBALVI Drug, CNS | 2022 | |
| 2022-10-12 | Alkermes, Inc. | $49 | Food and Beverage | In-kind items and services | LYBALVI Drug, CNS | 2022 |
The latest 200 records of 491.
CMS Open Payments: payments and transfers of value that drug and medical device makers and group purchasing organizations report to Medicare, program years 2019 on, as published by CMS (general, research and ownership records; refreshed by CMS each June and January). Links to other records on this site are by name (and state) only.
The area Census
County outline, the place (blue), the tract (orange) and the ZIP center (dot).
In Bay City, MI, county Bay County, MI, state Michigan; placed by its city name.
| Measure | Place (city or town) Bay City, MI | County Bay County, MI | State Michigan |
|---|---|---|---|
| Population B01003 | 32,320 | 103,008 | 10,077,761 |
| Population, 2020 census P1 | 32,661 | 103,856 | 10,077,331 |
| Median age B01002 | 40.7 | 43.9 | 40.2 |
| Under 18 B01001 | 20.2% | 19.6% | 21.2% |
| 65 and over B01001 | 17.7% | 21.9% | 18.6% |
| Households B11001 | 14,677 | 45,103 | 4,076,369 |
| Foreign born B05002 | 2.3% | 1.3% | 7.2% |
| Median household income B19013 | $49,420 | $61,763 | $72,875 |
| Median family income B19113 | $64,016 | $81,863 | $93,357 |
| Per capita income B19301 | $29,853 | $35,602 | $40,735 |
| Poverty rate B17001 | 19.1% | 13.2% | 13.2% |
| Unemployment rate B23025 | 6.7% | 4.3% | 5.7% |
| Civilian labor force B23025 | 15,738 | 50,658 | 5,018,449 |
| Mean commute (minutes) B08013 | 21.3 | 23.1 | 24.2 |
| Bachelor's degree or higher B15003 | 18.8% | 22.1% | 32.4% |
| Housing units B25001 | 16,078 | 48,659 | 4,622,236 |
| Owner-occupied B25003 | 70.1% | 77.0% | 73.2% |
| Renters B25003 | 29.9% | 23.0% | 26.8% |
| Median home value B25077 | $97,600 | $152,200 | $231,600 |
| Median gross rent B25064 | $766 | $860 | $1,129 |
| White, not Hispanic B03002 | 80.1% | 88.2% | 72.4% |
| Black B03002 | 1.6% | 1.0% | 13.1% |
| Hispanic or Latino B03002 | 11.5% | 5.9% | 5.9% |
| Asian B03002 | 0.8% | 0.5% | 3.4% |
| American Indian and Alaska Native B03002 | 0.1% | 0.1% | 0.3% |
Data: IPUMS NHGIS (ACS 2020-2024 and the 2020 census); each figure links to its table for that area at data.census.gov. Records are placed by ZIP code and city name, not street address. More: everything FURP has in Bay City, MI.
Comments